Explicitly it has a defined role in colon cancer and a combination of inactivation of the TGF-3 signaling pathway and expression of oncogenic Kras leads to formation of invasive intestinal neoplasms through a beta-catenin-independent pathway [48]. Here, KRAS is linked to intestinal neoplasm.